Medication info
Janugreen 25 mg (Sitagliptin Hydrochloride Hydrate)

Janugreen 25 mg (Sitagliptin Hydrochloride Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Sitagliptin Hydrochloride Hydrate›28.35mg / 1 tablet
Manufacturer / importer
Jin Yang Pharmaceutical Co., Ltd.
Appearance
Pink round biconvex film-coated tablets
Packaging
30 tablets/box [10 tablets/PTP×3]
Approval status
Active

MFDS item code 202005910 · Approved 2020.08.20 · Insurance code 650304330

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Administer 100 mg once daily as monotherapy or combination therapy; the maximum daily dose is 100 mg. This medicine may be taken with or without food. When coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions for Use, 5. General Precautions). Patients with renal impairment Because dose adjustment according to renal function is required, assessment of renal function is recommended before starting this medicine and periodically during treatment. 1. No dose adjustment is required in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dose adjustment is required in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily to patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily to patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medicine may be administered regardless of the timing of dialysis.

Ingredients

Manufacturer
Jin Yang Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Difficulty in blood sugar control in patients with type 2 diabetes
View approved original text

This medication is used to assist in the control of blood sugar in patients with type 2 diabetes. It can be administered alone or, if prior experience with diabetes medications exists or alone therapy is ineffective, it may be combined with metformin. Additionally, when monotherapy with sulfonylureas, metformin, thiazolidinediones, or insulin does not provide sufficient efficacy, this medication can be combined with these. Furthermore, if adequate blood sugar control is not achieved with combination therapy, this medication may be added to improve therapeutic outcomes. Therefore, this medication is effectively used in conjunction with dietary and exercise management to assist in blood sugar control.

How to take

Adult dose

Administer 100 mg once daily as monotherapy or combination therapy; the maximum daily dose is 100 mg. This medicine may be taken with or without food. When coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions for Use, 5. General Precautions). Patients with renal impairment Because dose adjustment according to renal function is required, assessment of renal function is recommended before starting this medicine and periodically during treatment. 1. No dose adjustment is required in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dose adjustment is required in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily to patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily to patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medicine may be administered regardless of the timing of dialysis.

Precautions

This medication may cause severe allergic reactions after administration, so if symptoms such as skin rash or difficulty breathing occur, it should be discontinued immediately and a doctor consulted. During the use of this medication, serious pancreatic inflammation called pancreatitis may occur, so should severe abdominal pain or vomiting arise, immediate medical attention should be sought. It should not be used in patients with type 1 diabetes or diabetic ketoacidosis, nor should it be administered to those with allergies to this medication or its components. Patients with impaired kidney function should have their dosage adjusted, and regular kidney function tests should be conducted according to the doctor's instructions. Colds and flu-like symptoms, headache, dyspepsia, diarrhea, nausea, etc., may occur during the use of this medication; if symptoms are severe, consulting healthcare professionals is advisable. When taken with insulin or sulfonylureas, the risk of hypoglycemia may increase, so blood sugar levels should be monitored frequently and should hypoglycemic symptoms occur, immediate action should be taken. If severe joint pain or blistering symptoms appear, the use of this medication should be stopped and a specialist should be consulted. Pregnant or breastfeeding women are advised to avoid this medication, and the safety and efficacy in children and adolescents under 18 have not been established. Elderly patients may experience decreased kidney function; therefore, regular kidney function tests before and after administration are needed, and dosage adjustment may be required. In case of overdose, immediate medical attention should be sought for appropriate treatment, and some of the drug may be removed through dialysis. This medication has relatively few drug interactions, but it is important to inform healthcare providers of any medications being taken, particularly when taken with immunosuppressants or cardiovascular drugs.

Side effects

Anaphylaxis, angioedema, Stevens-Johnson syndrome, acute pancreatitis, hypoglycemia, nasopharyngitis, upper respiratory infection, headache, diarrhea, abdominal pain, nausea, constipation, vomiting, rash, urticaria, cutaneous vasculitis, arthralgia with severe and disabling effects, bullous pemphigoid, myalgia, limb pain, back pain, interstitial lung disease, pruritus, thrombocytopenia, acute renal failure, peripheral edema, pneumonia, diabetic complications, metabolic acidosis, falls, cardiac arrest, dyspepsia, dizziness, increased serum triglycerides, gastritis, severe hypoglycemia, weight loss, hypertension, hypernatremia, erectile dysfunction, rhabdomyolysis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air exposure, at room temperature between 1 and 30 degrees Celsius. Proper storage helps maintain the medication's efficacy.

Appearance and packaging

Appearance

Pink round biconvex film-coated tablets

Package unit

30 tablets/box [10 tablets/PTP×3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.